Manufacturer of Next Generation Polymer-Based Products Settles Intellectual Property Agreement

Memry Corporation , an American Stock Exchange listed company focused on high-value engineering of nitinol-based and polymer-based next generation products for the medical device industry, announced today that it has entered into a settlement agreement and mutual release in connection with the Memry Corporation v. Kentucky Oil Technology, N.V., et al. litigation.

In consideration for the settlement agreement and mutual releases of all actions, Memry has paid $3,500,000 and assigned its rights to certain disputed intellectual property and its rights to receive certain royalty payments in connection with the disputed intellectual property to Kentucky Oil Technology, N.V., a Netherlands corporation. Memry also entered into settlement agreements and mutual releases with with other parties involved in the litigation, which do not provide for any payment obligations by any party to any other.

In connection with the settlement agreements, Memry and SAES Getters have agreed to amend the merger agreement entered into on June 24, 2008 to permit Memry to enter into the settlement agreements. The amendment also increases the price per share that Memry shareholders will be entitled to receive for each share of Memry common stock upon the closing of the merger from $2.51 per share to $2.53 per share.

For more information on polymer, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.